Trial Profile
Phase IIa trial of EP 217609 and its antidote, avidin, to prevent thrombosis in patients undergoing open-heart surgery.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 23 Jun 2011
Price :
$35
*
At a glance
- Drugs EP 217609 (Primary) ; Avidin; Heparin
- Indications Thrombosis
- Focus Adverse reactions
- Acronyms NOVEL
- 23 Jun 2011 New trial record